Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT RA: Zoledronic Acid for Prevention of Rheumatoid Arthritis
NCT04115397Phase 4Unknown
- Sponsor
- Karolinska Institutet
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in rheumatoid arthritis (RA), sponsored by Karolinska Institutet. Status: unknown.
02
Drugs
zoledronic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04115397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04115397.